Cerebrolysim
Here's the clean dosing-only format you requested:
Typical Dosing Protocols (Research/Compounded Use Only) – Cerebrolysin
Common protocol: 5–10 mL (one ampoule) intramuscularly or intravenously once daily for 10–20 consecutive days. Many users follow a 10-day course, then repeat every 3–6 months.
Other reported ranges:
Standard: 5 mL (one ampoule) daily for 10–20 days
Intensive: 10 mL (two ampoules) daily for 10–15 days
Maintenance: 5 mL daily for 5–10 days, repeated 2–3 times per year
Administration Notes:
Intramuscular (IM) injection is the most common route (usually into the glute or deltoid).
Intravenous (IV) slow infusion is also used in clinical settings.
Ampoules are typically 5 mL or 10 mL and do not require reconstitution — they are ready-to-use.
Cycle structure:
Most common: 10–20 days on → 3–6 months off
Some protocols use 5 days on / 2 days off for shorter courses.
Dosing is highly individualized based on goals (cognitive support, neuroprotection, recovery) and response—consult a qualified healthcare provider experienced with Cerebrolysin for personalized guidance. This is for informational purposes only.
Cerebrolysin – Subcutaneous Injection only
Typical daily dose: 20–32 mg once or twice daily (split doses if >20 mg).
Range: Start at 20 mg daily; titrate to 24–32 mg (some research protocols use 1 mL of standard 215 mg/mL solution ≈ 215 mg, but lower peptide-equivalent doses are common in self-administered contexts).
Frequency: Once daily (or split AM/PM for higher amounts).
Reconstitution example (common 60 mg vial + 3 mL bacteriostatic water ≈ 20 mg/mL): – 20 mg = 100 units (1.0 mL) – 24 mg = 120 units (1.2 mL) total, often split 60 units (0.6 mL) AM + 60 units (0.6 mL) PM – 28 mg = 140 units (1.4 mL) total, split 70 units (0.7 mL) AM + 70 units (0.7 mL) PM – 32 mg = 160 units (1.6 mL) total, split 80 units (0.8 mL) AM + 80 units (0.8 mL) PM on U-100 insulin syringe.
Titration example (over 4+ weeks):
Week 1: 20 mg daily (once)
Week 2: 24 mg daily (split)
Week 3: 28 mg daily (split)
Week 4+: 32 mg daily (split)
Cycle: Often 8–12 weeks (some extend to 16 weeks); courses of 40–80 days reported in lower-volume protocols.
Start low and titrate based on individual response and tolerance. Use sterile technique. Share exact vial size if you need adjusted unit calculations.
